BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wallmark B. Omeprazole: mode of action and effect on acid secretion in animals. Methods Find Exp Clin Pharmacol. 1989;11 Suppl 1:101-106. [PMID: 2657278 DOI: 10.1007/s10620-015-3959-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Offman J, Fitzgerald RC. Alternatives to Traditional Per-Oral Endoscopy for Screening. Gastrointest Endosc Clin N Am 2017;27:379-96. [PMID: 28577763 DOI: 10.1016/j.giec.2017.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
2 Yan J, Ma S, Zhang Y, Yin C, Zhou X, Zhang G. Potential role of microRNA-126 in the diagnosis of cancers: A systematic review and meta-analysis. Medicine (Baltimore) 2016;95:e4644. [PMID: 27583885 DOI: 10.1097/MD.0000000000004644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Spechler SJ, Katzka DA, Fitzgerald RC. New Screening Techniques in Barrett’s Esophagus: Great Ideas or Great Practice? Gastroenterology 2018;154:1594-601. [DOI: 10.1053/j.gastro.2018.03.031] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
4 Shen H, Zhang L, Zhou J, Chen Z, Yang G, Liao Y, Zhu M. Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1 (EFEMP1) Acts as a Potential Diagnostic Biomarker for Prostate Cancer. Med Sci Monit 2017;23:216-22. [PMID: 28085790 DOI: 10.12659/msm.898809] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
5 Fassan M, Facchin S, Munari G, Fanelli GN, Lorenzon G, Savarino E. Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa. World J Gastroenterol 2017; 23(43): 7653-7656 [PMID: 29209106 DOI: 10.3748/wjg.v23.i43.7653] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
6 Li X, Kleeman S, Coburn SB, Fumagalli C, Perner J, Jammula S, Pfeiffer RM, Orzolek L, Hao H, Taylor PR, Miremadi A, Galeano-Dalmau N, Lao-Sirieix P, Tennyson M, MacRae S, Cook MB, Fitzgerald RC. Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus. Gastroenterology. 2018;155:771-783.e3. [PMID: 29906417 DOI: 10.1053/j.gastro.2018.05.050] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
7 O'Donovan M, Fitzgerald RC. Screening for Barrett's Esophagus: Are New High-Volume Methods Feasible? Dig Dis Sci 2018;63:2105-14. [PMID: 29995243 DOI: 10.1007/s10620-018-5192-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sawas T, Killcoyne S, Iyer PG, Wang KK, Smyrk TC, Kisiel JB, Qin Y, Ahlquist DA, Rustgi AK, Costa RJ, Gerstung M, Fitzgerald RC, Katzka DA; OCCAMS Consortium. Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts. Gastroenterology 2018;155:1720-1728.e4. [PMID: 30165050 DOI: 10.1053/j.gastro.2018.08.036] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
9 Battaglin F, Naseem M, Puccini A, Lenz HJ. Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions. Cancer Cell Int. 2018;18:99. [PMID: 30008616 DOI: 10.1186/s12935-018-0594-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
10 Kong X, Gong S, Su L, Li C, Kong Y. Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas. J Cell Mol Med. 2018;22:123-130. [PMID: 28799211 DOI: 10.1111/jcmm.13300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Karkhane M, Lashgarian HE, Hormozi M, Fallahi S, Cheraghipour K, Marzban A. Oncogenesis and Tumor Inhibition by MicroRNAs and its Potential Therapeutic Applications: A Systematic Review. Microrna 2020;9:198-215. [PMID: 31686643 DOI: 10.2174/2211536608666191104103834] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Katzka DA, Fitzgerald RC. Time to Challenge Current Strategies for Detection of Barrett's Esophagus and Esophageal Adenocarcinoma. Dig Dis Sci 2020;65:18-21. [PMID: 31754994 DOI: 10.1007/s10620-019-05965-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Zhang Q, Bansal A. Role of Extracellular Vesicles in the Diagnosis and Pathogenesis of Barrett's Esophagus: A Mini-Review. Dig Dis Sci 2021;66:705-13. [PMID: 32277372 DOI: 10.1007/s10620-020-06250-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Yang C, Zheng S, Liu T, Liu Q, Dai F, Zhou J, Chen Y, Sheyhidin I, Lu X. Down-regulated miR-26a promotes proliferation, migration, and invasion via negative regulation of MTDH in esophageal squamous cell carcinoma. FASEB J 2017;31:2114-22. [PMID: 28174206 DOI: 10.1096/fj.201601237] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
15 Sanghi V, Thota PN. Barrett's esophagus: novel strategies for screening and surveillance. Ther Adv Chronic Dis 2019;10:2040622319837851. [PMID: 30937155 DOI: 10.1177/2040622319837851] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
16 di Pietro M, Canto MI, Fitzgerald RC. Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology. 2018;154:421-436. [PMID: 28778650 DOI: 10.1053/j.gastro.2017.07.041] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 16.0] [Reference Citation Analysis]
17 Yan J, She Q, Shen X, Zhang Y, Liu B, Zhang G. Potential Role of MicroRNA-375 as Biomarker in Human Cancers Detection: A Meta-Analysis. Biomed Res Int 2017;2017:1875843. [PMID: 29259977 DOI: 10.1155/2017/1875843] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lu D, Liu X, Feng S, Dong X, Shi X, Ren P, Diao D, Wu H, Xiong G, Wang H, Li M, Rao S, Molena D, Wu AJ, Cai K. The Current Situation of Esophageal Cancer Staging and Perioperative Strategies Determination in Central and Southern China: A Cross Sectional Survey. Front Oncol 2019;9:1098. [PMID: 31696056 DOI: 10.3389/fonc.2019.01098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Codipilly DC, Iyer PG. Novel Screening Tests for Barrett's Esophagus. Curr Gastroenterol Rep 2019;21:42. [PMID: 31346777 DOI: 10.1007/s11894-019-0710-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wani S, Rubenstein JH, Vieth M, Bergman J. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association. Gastroenterology 2016;151:822-35. [PMID: 27702561 DOI: 10.1053/j.gastro.2016.09.040] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 15.4] [Reference Citation Analysis]
21 Clark RJ, Craig MP, Agrawal S, Kadakia M. microRNA involvement in the onset and progression of Barrett's esophagus: a systematic review. Oncotarget 2018;9:8179-96. [PMID: 29487725 DOI: 10.18632/oncotarget.24145] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
22 Xu J, Yin Z, Yang L, Wu F, Fan J, Huang Q, Jin Y, Yang G. Evidence that dysplasia related microRNAs in Barrett's esophagus target PD-L1 expression and contribute to the development of esophageal adenocarcinoma. Aging (Albany NY) 2020;12:17062-78. [PMID: 32903213 DOI: 10.18632/aging.103634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Yan X, Zhu S, Zhang H. miR-203 Expression in Exfoliated Cells of Tongue Coating Represents a Sensitive and Specific Biomarker of Gastroesophageal Reflux Disease. Gastroenterol Res Pract 2016;2016:2349453. [PMID: 27667995 DOI: 10.1155/2016/2349453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Abraham JM, Meltzer SJ. Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma. Gastroenterology 2017;153:27-34. [PMID: 28528706 DOI: 10.1053/j.gastro.2017.04.046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
25 Craig MP, Rajakaruna S, Paliy O, Sajjad M, Madhavan S, Reddy N, Zhang J, Bottomley M, Agrawal S, Kadakia MP. Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus. Clin Transl Gastroenterol 2020;11:e00125. [PMID: 31934893 DOI: 10.14309/ctg.0000000000000125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
26 Porter RJ, Murray GI, Brice DP, Petty RD, McLean MH. Novel biomarkers for risk stratification of Barrett's oesophagus associated neoplastic progression-epithelial HMGB1 expression and stromal lymphocytic phenotype. Br J Cancer 2020;122:545-54. [PMID: 31831860 DOI: 10.1038/s41416-019-0685-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Hou Y, Hu Q, Huang J, Xiong H. Omeprazole Inhibits Cell Proliferation and Induces G0/G1 Cell Cycle Arrest through Up-regulating miR-203a-3p Expression in Barrett's Esophagus Cells. Front Pharmacol 2017;8:968. [PMID: 29375376 DOI: 10.3389/fphar.2017.00968] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
28 Sami SS, Iyer PG. Recent Advances in Screening for Barrett's Esophagus. Curr Treat Options Gastroenterol 2018;16:1-14. [PMID: 29330747 DOI: 10.1007/s11938-018-0166-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
29 Kaz AM, Grady WM. Novel Barrett's esophagus screening assays based on swallowable devices: will they change the game? Transl Gastroenterol Hepatol 2019;4:25. [PMID: 31143846 DOI: 10.21037/tgh.2019.04.01] [Reference Citation Analysis]
30 Tan WK, Sharma AN, Chak A, Fitzgerald RC. Progress in Screening for Barrett's Esophagus: Beyond Standard Upper Endoscopy. Gastrointest Endosc Clin N Am 2021;31:43-58. [PMID: 33213799 DOI: 10.1016/j.giec.2020.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]